News

Medpage Today on MSN1mon
Updated CKD Guidelines Promote Cystatin C, Risk Equations, and SGLT2 Inhibitors
Use of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization ...
Renal & Urology News7dOpinion
Why the US Needs Independent Kidney Care Guidelines for American Patients
A nephrologist argues that advancing kidney care in the US requires tailored guidelines addressing ethnic diversity & ...
The American Journal of Managed Care2d
Overview of Treatment Landscape for IgA Nephropathy: Standard of Care and KDIGO Guidelines
Panelists discuss how immunoglobulin A (IgA) nephropathy treatment has evolved to include supportive care with optimized ...
Medscape5d
Complexities of Vitamin D in CKD Require Individualization
Benefits from vitamin D supplementation in kidney disease vary; routine testing is not recommended in otherwise healthy ...
The American Journal of Managed Care16d
Meta-Analysis Finds SGLT2 Inhibitors Boost Hemoglobin, Hematocrit in CKD
SGLT2 inhibitors significantly improve hemoglobin and hematocrit levels in CKD patients, enhancing anemia management. The KDIGO 2024 guideline endorses SGLT2 inhibitors for CKD patients ...
Medscape10d
Chronic Kidney Disease News
Medscape News UK, March 18, 2025 Major Changes Highlighted in New CKD Management Guidelines Use of cystatin ... are among the changes put forth by KDIGO. Medscape Medical News, March 14, 2025 ...